Obligation Barclay PLC 2.57% ( XS1962236144 ) en PLN

Barclay PLC

100 % ▲

Royaume-Uni

XS1962236144 ( en PLN )

2.57% par an ( paiement annuel )

17/06/2024 - Obligation échue

Prospectus brochure de l'obligation Barclays PLC XS1962236144 en PLN 2.57%, échue

5 000 PLN

5 850 000 PLN

Barclays PLC est une banque multinationale britannique offrant une large gamme de services financiers, notamment la banque de détail, la gestion de patrimoine, la banque d'investissement et les cartes de crédit, opérant dans de nombreux pays à travers le monde.

L'Obligation émise par Barclay PLC ( Royaume-Uni ) , en PLN, avec le code ISIN XS1962236144, paye un coupon de 2.57% par an.
Le paiement des coupons est annuel et la maturité de l'Obligation est le 17/06/2024

SECURITIES NOTE RELATING TO GSSP BASE PROSPECTUS 1B

BARCLAYS BANK PLC
(Incorporated with limited liability in England and Wales)
LEI: G5GSEF7VJP5I7OUK5573
Pursuant to the Global Structured Securities Programme
What is this document?
This securities note (the "Securities Note" or the "Document"), together with the Registration Document
(as described below), constitutes a base prospectus drawn up as separate documents (the "Base
Prospectus") for the purposes of Article 8 of Regulation (EU) 2017/1129 (as amended, the "EU
Prospectus Regulation"). The Base Prospectus is one of a number of base prospectuses of Barclays
Bank PLC (the "Issuer") which relate to the Issuer's Global Structured Securities Programme (the
"Programme"). The Base Prospectus (as may be supplemented from time to time) is valid for 12 months
after its approval and will expire on 25 August 2023. The obligation to supplement a prospectus in the
event of any significant new factor, material mistake or material inaccuracy relating to the information
included in it does not apply when the prospectus is no longer valid.
What is the Registration Document?
The Issuer's registration document 9/2022 dated 1 June 2022 (as supplemented on 24 August 2022 and
as may be further supplemented from time to time, the "Registration Document") has been approved
by the Central Bank of Ireland (the "CBI") pursuant to the EU Prospectus Regulation. The Registration
Document provides a description of the Issuer's business activities as well as certain financial information
and material risks faced by the Issuer. The Registration Document and the supplements thereto are
available for viewing at: https://home.barclays/investor-relations/fixed-income-investors/prospectus-
and-documents/structured-securities-prospectuses/#registrationdocument
and
https://home.barclays/investor-relations/fixed-income-investors/prospectus-and-documents/structured-
securities-prospectuses/#registrationdocumentsupplement.
What type of Securities does the Base Prospectus relate to?
The Base Prospectus ("GSSP Base Prospectus 1B") relates to the issuance of securities (the
"Securities"), which will bear fixed rate interest, floating rate interest, inverse floating rate interest,
decompounded floating rate interest, interest that is linked to the performance of a specified inflation
index, a fixed rate of interest that will vary between two specified fixed rates (one of which may be zero)
depending on whether a specified floating rate equals or exceeds a specified strike rate or a rate of interest
linked to the spread between two floating rates, may be zero coupon securities (which do not bear
interest) or may apply a combination of different interest types. The amount of interest payable in respect
of Securities on an interest payment date may be subject to a range accrual factor that will vary depending
on the performance of a specified inflation index or one or more specified floating rates during the
observation period relating to that interest payment date. The type of interest (if any) payable on the
Securities may be the same for all interest payment dates or may be different for different interest
payment dates. Securities may also contain a provision which allows the Issuer to switch the type of
interest payable on specified dates before maturity.
Upon maturity, the Securities will either pay a fixed redemption amount or a redemption amount that is
linked to the performance of a specified inflation index. In addition, the Securities may provide for early
redemption at the option of the issuer (a call option) or the investor (a put option).
Application has been made to the Irish Stock Exchange plc trading as Euronext Dublin ("Euronext
Dublin") for Securities issued under the Programme during the period of 12 months from the date of this
Base Prospectus to be listed on the official list of Euronext Dublin and admitted to trading on its regulated
market.

1

Who is the Issuer?
The Issuer of the Securities is Barclays Bank PLC. The payment of any amount due under the Securities
is subject to the Issuer's financial position and its ability to meet its obligations. The legal entity identifier
("LEI") in respect of the Issuer is G5GSEF7VJP5I7OUK5573.
How do I use the Base Prospectus?
The Base Prospectus, together with certain other documents listed within, is intended to provide you with
information necessary to enable you to make an informed investment decision before purchasing any
Securities.
The contractual terms of any particular issuance of Securities will be composed of the terms and
conditions set out at pages 53 to 197 of this Securities Note (the "General Conditions"), as completed
by a separate Final Terms (as defined below) document, which is specific to that issuance of Securities.
The General Conditions comprise five Sections (A. to E.):
·
Sections A.: INTRODUCTION, B.: FORM, TITLE, TRANSFER, CALCULATIONS AND
PAYMENTS UNDER THE SECURITIES and E.: GENERAL PROVISIONS are generic
provisions which apply to issuances of Securities generally;
·
Sections C.: INTEREST, OPTIONAL EARLY REDEMPTION AND FINAL REDEMPTION
and D.: INFLATION INDEX DISRUPTION EVENTS contain certain optional provisions that
will only apply to certain issuances of Securities. The Final Terms document will specify which
provisions from Section C. apply to your Securities. Section D. will only apply to Securities that
bear interest or pay a redemption amount that is linked to the performance of a specified inflation
index.
The provisions from Section C. that are specified to be applicable in the Final Terms will contain the
relevant economic terms applicable to your Securities as follows:
·
the relevant sub-paragraph of General Condition 7 (Interest) sets out how any interest amounts
will be calculated;
·
General Condition 8 (Optional Early Redemption) will specify whether the Issuer, or investors,
have the right to redeem the Securities early and at what amount; and
·
General Condition 9 (Final Redemption) will specify how the redemption amount is calculated
upon maturity.
This Securities Note also includes other general information such as information about the material risks
relating to investing in Securities (see the section headed 'RISK FACTORS' of this Securities Note) and
information on selling and transfer restrictions. The Registration Document provides a description of the
Issuer's business activities as well as certain financial information and material risks faced by the Issuer.
All capitalised terms used will be defined in the Base Prospectus or the Final Terms and are referenced
in the Index to this Document or the Index of Abbreviations to the Registration Document, as applicable.
What other documents do I need to read?
The Registration Document and this Securities Note contain all information which is necessary to enable
investors to make an informed decision regarding the financial position and prospects of the Issuer and
the rights attaching to the Securities. Some of this information is incorporated by reference from other
publicly available documents and some of this information is completed in an issue-specific document
called the Final Terms. You should read the documents incorporated by reference, as well as the Final
Terms in respect of such Securities, together with the Registration Document and this Securities Note.
Documents will be made available at the registered office of the Issuer and at
https://home.barclays/investor-relations/fixed-income-investors/prospectus-and-documents/structured-
securities-prospectuses/,
https://home.barclays/investor-relations/fixed-income-investors/prospectus-

2

and-documents/structured-securities-final-terms and https://home.barclays/investor-relations/reports-
and-events (as applicable) or the successor website(s).
What information is included in the Final Terms?
While this Securities Note includes general information about all Securities, the Final Terms is the
document that sets out the specific details of each particular issuance of Securities (the "Final Terms").
For example, the Final Terms may contain:
·
the issue date;
·
the scheduled redemption date;
·
the interest payment dates (if any);
·
the type of interest that applies in respect of each interest payment date (if any);
·
the type of final redemption;
·
whether or not the Securities may be redeemed early at the option of the Issuer or the investor;
and
·
any other information needed to complete the terms included in this Securities Note for the
particular Securities (identified by the words 'as specified in the Final Terms' or other equivalent
wording).
Wherever the General Conditions provide optional provisions, the Final Terms will specify which of
those provisions apply to a specific issuance of Securities. In addition, an issue-specific summary will
be annexed to the Final Terms for each issuance of Securities which will contain a summary of key
information relating to the Issuer and the Securities, the risks relating to the Issuer and the Securities and
the issue or offer of Securities. The form of Final Terms applicable to Securities is set out in the section
headed 'FORM OF FINAL TERMS' of this Securities Note.
What type of Underlying Assets may the Securities be linked to?
The interest and repayment terms of the Securities may be linked to:
·
a reference rate for determining floating rate interest;
·
a reference rate for determining the fixed rate at which digital interest is payable;
·
two reference rates for determining spread-linked interest;
·
one or more reference rates for determining the applicable range accrual factor (if any); and/or
·
movements in an inflation index,
(each being an "Underlying Asset").
In addition, certain Securities issued under the Base Prospectus may pay fixed interest amounts and/or a
fixed repayment amount. Such interest amounts and/or repayment amount (as applicable) will not be
linked to an Underlying Asset.
The Securities have not been, and will not be, at any time, registered under the U.S. Securities Act of
1933. The Securities may not be offered, sold, transferred, pledged, assigned, delivered, exercised or
redeemed within the United States or to, or for the account or benefit of, any U.S. person.

25 August 2022

3

Important Information
IMPORTANT INFORMATION
THE AMOUNT PAYABLE ON REDEMPTION OF THE SECURITIES MAY BE LESS THAN
THE ORIGINAL INVESTED AMOUNT (AND IN SOME CASES MAY BE ZERO), IN WHICH
CASE YOU MAY LOSE SOME OR ALL OF YOUR ORIGINAL INVESTMENT.
FOR ALL SECURITIES, IF THE ISSUER BECOMES INSOLVENT OR BANKRUPT OR
OTHERWISE FAILS TO MAKE ITS PAYMENT OBLIGATIONS ON THE SECURITIES, YOU
WILL LOSE SOME OR ALL OF YOUR ORIGINAL INVESTMENT.
INVESTING IN SECURITIES INVOLVES CERTAIN RISKS, AND YOU SHOULD FULLY
UNDERSTAND THESE BEFORE YOU INVEST. SEE THE SECTION HEADED 'RISK
FACTORS' BELOW.
Responsibility
The Issuer accepts responsibility for the information contained in this Securities Note (and for the
avoidance of doubt, in the Base Prospectus) and any Final Terms. To the best of the knowledge of the
Issuer, the information contained in this Securities Note is in accordance with the facts and this Securities
Note makes no omission likely to affect its import.
Regulatory approval and passporting for the purposes of the EU Prospectus Regulation
This Securities Note (and for the avoidance of doubt, the Base Prospectus) has been approved by the
Central Bank of Ireland as competent authority under the EU Prospectus Regulation. The Central Bank
of Ireland only approves the Securities Note as meeting the standards of completeness, comprehensibility
and consistency imposed by the EU Prospectus Regulation.
Such approval should not be considered as an endorsement of the Issuer or the quality of the securities
that are the subject of the Base Prospectus. Investors should make their own assessment as to the
suitability of investing in the securities.
Notification of this approval has been made to the competent authorities of Belgium, Denmark, Finland,
France, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain and Sweden.
Such approval relates only to Securities which are to be admitted to trading on a regulated market for the
purposes of Directive 2014/65/EU and Regulation (EU) No.600/2014 (as amended, "MiFID II") and/or
which are to be offered to the public in any Member State of the European Economic Area.
Listing and admission to trading
Application may be made for the listing and admission to trading of Securities on the regulated market
of the Irish Stock Exchange plc trading as Euronext Dublin.
In addition, application may be made for the listing and admission to trading of Securities on the
regulated market of the Luxembourg Stock Exchange, Euronext Paris, Euronext Brussels, Euronext
Amsterdam, Malta Stock Exchange, NASDAQ Copenhagen, NASDAQ Helsinki, NASDAQ Stockholm,
NGM Nordic Derivatives Exchange (NDX), Oslo Stock Exchange, Borsa Italiana S.p.A., Bolsas y
Mercados Españoles and/or Euronext Lisbon, if specified in the Final Terms.
In addition, application may be made for the listing and admission to trading of Securities on the SIX
Swiss Exchange and/or on the multilateral trading facility of EuroTLX SIM S.p.A., Euro MTF, the
Nasdaq Structured Products MTF segment of Nasdaq First North Finland, Nasdaq Stockholm Structured
Products MTF, NGM Nordic MTF and SeDex (MTF), if specified in the Final Terms. The SIX Swiss
Exchange and the multilateral trading facility of EuroTLX SIM S.p.A., Euro MTF, the Nasdaq Structured
Products MTF segment of Nasdaq First North Finland, Nasdaq Stockholm Structured Products MTF,
NGM Nordic MTF and SeDex (MTF) are not regulated markets for the purposes of MiFID II.
No compensation arrangements
Any failure by the Issuer to make payments due under the Securities would not of itself give rise to any
claim for compensation on the grounds of such a failure. You would not have a claim for compensation

4

Important Information
against the UK's Financial Services Compensation Scheme. For more information regarding Issuer risk,
please see the section headed 'RISK FACTORS' of the Registration Document.
No investment advice
Neither the Base Prospectus nor any Final Terms is or purports to be investment advice. Unless expressly
agreed otherwise with a particular investor, neither the Issuer nor any Manager is acting as an investment
adviser, providing advice of any other nature, or assuming any fiduciary obligation to any investor in
Securities.
Independent evaluation
Nothing set out or referred to in the Base Prospectus is intended to provide the basis of any credit or other
evaluation (except in respect of any purchase of Securities described herein) or should be considered as
a recommendation by the Issuer or any Manager that any recipient of the Base Prospectus (or any
document referred to herein) should purchase any Securities.
An investor should not purchase the Securities unless they understand the extent of their exposure to
potential loss. Investors are urged to read (i) the risks described in the section headed 'RISK FACTORS'
of this Document and (ii) the risks described in the section headed 'RISK FACTORS' of the Registration
Document, together with the other information in the Base Prospectus (including any information
incorporated by reference), as supplemented from time to time, and the Final Terms, before investing in
the Securities.
Investors should note that (i) the risks described in the section headed 'RISK FACTORS' of this Document
and (ii) the risks described in the section headed 'RISK FACTORS' of the Registration Document are not
the only risks that the Issuer faces or that may arise because of the nature of the Securities. The Issuer
has described only those risks relating to its operations and to the Securities that it considers to be
material. There may be additional risks that the Issuer currently considers not to be material or of which
it is not currently aware.
Given the nature, complexity and risks inherent in the Securities (and investments relating to any
underlying assets), the Securities may not be suitable for an investor's investment objectives in the light
of his or her financial circumstances. Investors should consider seeking independent advice to assist them
in determining whether the Securities are a suitable investment for them or to assist them in evaluating
the information contained or incorporated by reference into the Base Prospectus or set out in the Final
Terms.
You have sole responsibility for the management of your tax and legal affairs including making any
applicable filings and payments and complying with any applicable laws and regulations. Neither the
Issuer nor any of its Affiliates will provide you with tax or legal advice and you should obtain your own
independent tax and legal advice tailored to your individual circumstances. The tax treatment of
structured products, such as the Securities, can be complex; the tax treatment applied to an individual
depends on their circumstances. The level and basis of taxation may alter during the term of any product.
Amounts due to be paid to you are described on a gross basis, i.e. without calculating any tax liability.
The Issuer shall make no deduction for any tax, duty, or other charge unless required by law.
Potential for discretionary determinations by the Issuer and the Determination Agent under the
Securities
Under the terms and conditions of the Securities, following the occurrence of certain events relating to
the Issuer, (save for Belgian Securities) the Issuer's hedging arrangements, the Underlying Asset(s),
taxation, the relevant currency or other matters, the Issuer or the Determination Agent may determine to
take one of the actions available to it in order to deal with the impact of such event on the Securities or
the Issuer or both. These actions may include (i) adjustment to the terms and conditions of the Securities
(including, without limitation, replacement of the Reference Rate), (ii) substitution of the Underlying
Asset(s) or (iii) early redemption of the Securities. Any such discretionary determination by the Issuer
or Determination Agent could have a material adverse impact on the value of and return on the Securities.
See, in particular, risk factor 6.1 (Risks associated with discretionary powers, or with respect to certain
French Notes, decision-making powers, of the Issuer and the Determination Agent, including in relation
to the Issuer's hedging arrangements) below.

5

Important Information
Under certain circumstances, amendments made by the Issuer or the Determination Agent to the
Conditions of French Notes may require the prior consent of the General Meeting of the Holders when
the 'Full Masse' or 'Contractual Masse' is specified as applicable in the Final Terms in accordance with
General Condition 25.3 (Modifications of French Notes).
Distribution
The distribution or delivery of the Base Prospectus or any Final Terms and any offer or sale of Securities
in certain jurisdictions may be restricted by law. The Base Prospectus does not constitute, and may not
be used for the purposes of, an offer or solicitation by anyone in any jurisdiction in which such offer or
solicitation is not authorised or to any person to whom it is unlawful to make such offering or solicitation.
Other than as expressly described in the Base Prospectus, no action is being taken to permit an offering
of Securities or the delivery of the Base Prospectus in any jurisdiction. Persons into whose possession
the Base Prospectus or any Final Terms come are required by the Issuer to inform themselves about and
to observe any such restrictions.
Details of selling restrictions for various jurisdictions are set out in the section headed 'PURCHASE AND
SALE' of this Document.
United States selling restrictions
In relation to Securities which are being offered and sold outside the United States in reliance on
Regulation S only, there are restrictions on the Issuer and its Affiliates (including Barclays Bank PLC in
its role as Manager) making sales of Securities in the United States, including for market making
purposes.
The Securities have not been and will not be, at any time, registered under the U.S. Securities Act of
1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other
jurisdiction of the United States. The Securities may not be offered or sold within the United States or
to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act
("Regulation S")) ("U.S. persons"), except in certain transactions exempt from the registration
requirements of the Securities Act and applicable state securities laws. Trading in the Securities has not
been approved by the U.S. Commodities Futures Trading Commission under the U.S. Commodity
Exchange Act of 1936, as amended (the "Commodity Exchange Act") and the rules and regulations
promulgated thereunder. The Securities are being offered and sold outside the United States to non-U.S.
persons in reliance on Regulation S.
Securities in bearer form may be subject to U.S. tax law requirements (as described below). Subject to
certain exceptions, the Securities may not be offered, sold or delivered within the United States or its
possessions or to, or for the account or benefit of, United States persons (as defined in the U.S. Internal
Revenue Code of 1986, as amended, (the "Code") and the regulations thereunder).
For a description of these and certain further restrictions on offers, sales and transfers of Securities and
delivery of the Base Prospectus and any Final Terms, see the section entitled 'PURCHASE AND SALE'
herein.
THE SECURITIES HAVE NOT BEEN AND WILL NOT BE APPROVED OR DISAPPROVED BY
THE U.S. SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES
COMMISSION IN THE UNITED STATES OR ANY OTHER U.S. REGULATORY AUTHORITY,
NOR HAVE ANY OF THE FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE
MERITS OF THE OFFERING OF SECURITIES OR THE ACCURACY OR THE ADEQUACY OF
THE OFFERING DOCUMENTS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENCE IN THE UNITED STATES.
U.S. foreign account tax compliance withholding
THE FOREIGN ACCOUNT TAX COMPLIANCE ACT ("FATCA") IS PARTICULARLY
COMPLEX AND ITS CURRENT AND FUTURE APPLICATION TO THE ISSUER, THE
SECURITIES AND INVESTORS IS UNCERTAIN AT THIS TIME. YOU SHOULD CONSULT
YOUR OWN TAX ADVISERS TO OBTAIN A MORE DETAILED EXPLANATION OF FATCA
AND TO LEARN HOW THIS LEGISLATION MIGHT AFFECT YOU IN YOUR
PARTICULAR CIRCUMSTANCE, INCLUDING HOW THE FATCA RULES MAY APPLY TO

6

Important Information
PAYMENTS RECEIVED UNDER THE SECURITIES BOTH CURRENTLY AND IN THE
FUTURE.
Change of circumstances
Neither the delivery of the Base Prospectus (including any information incorporated by reference in the
Base Prospectus) or any Final Terms, nor any sale of Securities, shall create any impression that
information in such documents relating to the Issuer is correct at any time subsequent to the date of the
Registration Document (as supplemented) or that any other information supplied in connection with the
Securities or the Programme is correct as of any time subsequent to the date of the relevant document
containing the same (the foregoing being without prejudice to the Issuer's obligations under applicable
rules and regulations).
Unauthorised representations and solicitations
In connection with the issue and sale of Securities, no person has been authorised to give any information
or to make any representation not contained in or consistent with the Base Prospectus and Final Terms
and, if given or made, such information or representation must not be relied upon as having been
authorised by the Issuer. The Issuer does not accept responsibility for any information not contained in
the Base Prospectus and Final Terms. The Base Prospectus does not constitute, and may not be used for
the purposes of, an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation
is not authorised or to any person to whom it is unlawful to make such offering or solicitation and no
action is being taken to permit an offering of the Securities or the distribution of the Base Prospectus in
any jurisdiction where action is required.
Representations in relation to Swiss Securities
If you purchase Swiss Securities, you shall be deemed to have agreed to be bound by the exercise of any
UK Bail-In Power by the Relevant UK Resolution Authority. See General Condition 3 (Contractual
acknowledgement of bail-in in respect of Swiss Securities).
Representations in relation to French Securities
If you purchase French Securities, you shall be deemed to have agreed to be bound by the exercise of
any UK Bail-In Power by the Relevant UK Resolution Authority. See General Condition 4 (Contractual
acknowledgement of bail-in in respect of French Securities).
Calculations and determinations
Unless otherwise specified, all calculations and determinations in respect of the Securities shall be made
by either Barclays Bank PLC or Barclays Capital Securities Limited (acting in such capacity, the
"Determination Agent").
Use of a benchmark
Amounts payable under the Securities may be calculated or otherwise determined by reference to an
index or a combination of indices. Any such index may constitute a benchmark for the purposes of
Regulation (EU) 2016/1011 (as amended, the "EU Benchmarks Regulation"). If any such index does
constitute such a benchmark, the Final Terms will indicate whether or not the benchmark is provided by
an administrator included in the register of administrators and benchmarks established and maintained
by the European Securities and Markets Authority ("ESMA") pursuant to Article 36 of the EU
Benchmarks Regulation. Not every index will fall within the scope of the EU Benchmarks Regulation.
Transitional provisions in the EU Benchmarks Regulation may have the result that the administrator of
a particular benchmark is not required to appear in the register of administrators and benchmarks at the
date of the Final Terms. The registration status of any administrator under the EU Benchmarks
Regulation is a matter of public record and, save where required by applicable law, the Issuer does not
intend to update the Final Terms to reflect any change in the registration status of the administrator.

7

Important Information
Language
The language of this Base Prospectus is English. Certain legislative references and technical terms have
been cited in their original language in order that the correct technical meaning may be ascribed to them
under applicable law.
Definitions relating to Barclays entities
In this Document, "Group" or "Barclays" mean Barclays PLC together with its subsidiaries, term
"Barclays Bank Group" means Barclays Bank PLC together with its subsidiaries and the term
"Barclays Group" means Barclays PLC and Barclays Bank PLC together with their subsidiaries.

8

TABLE OF CONTENTS

Page
RISK FACTORS
11
This section sets out the principal risks inherent in investing in Securities issued pursuant to

the Programme, including key risks relating to investments linked to the Underlying Asset(s).
GENERAL DESCRIPTION OF THE PROGRAMME
48
This section provides an overview of certain key features of the programme.

Information incorporated by reference
51
This section incorporates certain information in respect of the Securities.

TERMS AND CONDITIONS OF THE SECURITIES
53
This section sets out the contractual terms of the Securities. Section C contains certain options

for determining interest payments (if any), optional redemption rights (if any) and final
redemption payments and the Final Terms will indicate which of these options shall apply.
A.
INTRODUCTION

B.
FORM, TITLE, TRANSFER, CALCULATIONS AND PAYMENTS UNDER THE

SECURITIES

1
Form, title and transfer
55

2
Status
62

3
Contractual acknowledgement of bail-in in respect of Swiss Securities
62

4
Contractual acknowledgement of bail-in in respect of French Securities
63

5
Calculations and publication
63

6
Payments
65

C.
INTEREST, OPTIONAL EARLY REDEMPTION AND FINAL REDEMPTION
68

7
Interest
68

8
Optional Early Redemption
129

9
Final Redemption
131

D.
INFLATION INDEX DISRUPTION EVENTS
133

10
Inflation Index Disruption Events
133

11
Consequences of FX Disruption Events
136

E.
GENERAL PROVISIONS
137

12
Accrual of Interest
137

13
Adjustment or early redemption following an Additional Disruption Event
137

14
Early Redemption following an unscheduled early redemption event -
138
Belgian Securities

15
Administrator/Benchmark Event
139

16
Indicative amounts
140

17
Events of Default
140

18
Agents
141

19
Taxation
143

20
Prescription
144

21
Replacement of Securities (other than Danish Securities, Finnish Securities,
144
French Securities, Norwegian Securities or Swedish Securities)

22
Early redemption for unlawfulness or impracticability
145

23
Notices
146

24
Substitution (Securities other than French Securities and Belgian
147
Securities)

25
Modifications and Meetings of Holders
149

9

26
Further issues
155

27
Purchases and cancellations

28
Governing law and jurisdiction
156

29
Severability
157

30
Contracts (Rights of Third Parties) Act 1999
157

31
Definitions and Interpretation
157

FORM OF FINAL TERMS
198
This section sets out a template for the Final Terms to be used for each specific issuance of

Securities.
CLEARANCE AND SETTLEMENT
246
This section sets out additional conditions relating to the clearing system for the Securities.

TAXATION
247
This section sets out an overview of certain taxation considerations relating to Securities.

PURCHASE AND SALE
291
This section sets out an overview of certain restrictions around who can purchase the

Securities in certain jurisdictions.
IMPORTANT LEGAL INFORMATION
301
This section provides important legal information relating to all Securities.

GENERAL INFORMATION
308
This section provides certain additional information relating to the Securities.

INDEX
314
An index of all defined terms used in this Document.

10